143 related articles for article (PubMed ID: 3242960)
1. [Blood products and plasma derivatives].
Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960
[No Abstract] [Full Text] [Related]
2. [Current therapy with blood and blood derivatives].
Gelabert A; Puig L; Mazzara R
Med Clin (Barc); 1983 Apr; 80(12):550-9. PubMed ID: 6345950
[No Abstract] [Full Text] [Related]
3. [Optimum use of human blood].
van Aken WG; Brummelhuis HG; Prins HK; von dem Borne AE
Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1362-75. PubMed ID: 692763
[No Abstract] [Full Text] [Related]
4. [Blood component therapy (author's transl)].
Kretschmer V
Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
[TBL] [Abstract][Full Text] [Related]
5. [Blood component transfusion in Croatia].
Grgicević D; Bozović I; Pende B
Bilt Hematol Transfuz; 1978; 6(3):13-29. PubMed ID: 757666
[TBL] [Abstract][Full Text] [Related]
6. [Indications for blood products].
Vezon G
Rev Prat; 1989 Sep; 39(20):1752-61. PubMed ID: 2814258
[TBL] [Abstract][Full Text] [Related]
7. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
8. [Replacing the administration of whole blood with blood derivatives].
Baklaja R
Bilt Hematol Transfuz; 1982; 10(2-3):115-29. PubMed ID: 6927292
[No Abstract] [Full Text] [Related]
9. [The use of plasma substitutes and albumin in blood component therapy].
Lundsgaard-Hansen P; Tschirren B
Klin Anasthesiol Intensivther; 1980; 21():120-35. PubMed ID: 7453077
[No Abstract] [Full Text] [Related]
10. [Blood component therapy today].
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
[No Abstract] [Full Text] [Related]
11. Use of blood components in clinical practice. Blood components.
Norris BF
N Y State J Med; 1971 Jun; 71(12):1518-22. PubMed ID: 4102706
[No Abstract] [Full Text] [Related]
12. The development of plasma derivatives in Australia.
Schiff P
Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
[No Abstract] [Full Text] [Related]
13. [The possibility of blood component therapy in Croatia (author's transl)].
Grgicević D; Bozović I; Pende B
Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696
[No Abstract] [Full Text] [Related]
14. [Rationalization of the use of blood and blood preparations].
Ninomiya K
Rinsho Byori; 1991 Mar; Suppl 88():20-8. PubMed ID: 1856969
[No Abstract] [Full Text] [Related]
15. Selected topics in blood component therapy.
Wallas CH
Prog Clin Pathol; 1984; 9():47-64. PubMed ID: 6420839
[No Abstract] [Full Text] [Related]
16. [New aspects of therapy with blood and blood components].
Frick U; Frick G
Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
[TBL] [Abstract][Full Text] [Related]
17. Plasma for fractionation: safety and quality issues.
Farrugia A
Haemophilia; 2004 Jul; 10(4):334-40. PubMed ID: 15230946
[TBL] [Abstract][Full Text] [Related]
18. [Blood component therapy in intensive medicine].
Blauhut B
Klin Anasthesiol Intensivther; 1980; 21():152-68. PubMed ID: 7453078
[No Abstract] [Full Text] [Related]
19. [Clinical importance of human plasma proteins and their future development].
Schwick HG
Beitr Infusionsther; 1991; 28():115-23. PubMed ID: 1725608
[TBL] [Abstract][Full Text] [Related]
20. [Blood transfusion. 2. Blood derivatives and plasma fractions].
Wehrlin N
Rev Infirm; 1975 Apr; 25(4):299-306. PubMed ID: 1039093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
